symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
PARNF,0.0004,21.986864,1113,2867032,0,3.0E-4-0.02,-0.0001,Parnell Pharmaceuticals Holdings Ltd,USD,,,,Other OTC,PNK,Drug Manufacturersâ€”Specialty & Generic,https://www.parnell.com,"Parnell Pharmaceuticals Holdings Ltd, a commercial-stage pharmaceutical company, focuses on developing, manufacturing, and marketing animal pharmaceutical products worldwide. The company operates through four segments: Companion Animal, Production Animal - U.S., Production Animal - Rest of World, and Manufacturing Operations. It markets various products, including estroPLAN and GONAbreed reproductive hormone products for enhancing cattle breeding performance; Zydax for the treatment of osteoarthritis (OA) in dogs and horses; and Glyde, a nutraceutical product for the treatment of OA, as well as Parnell PROcept, which adds an additional injection of estroPLAN after the first injection. The company also offers mySYNCH, a digital tool to help veterinarians and producers optimize reproduction and maximize economic gains. Parnell Pharmaceuticals Holdings Ltd was incorporated in 2009 and is headquartered in Alexandria, Australia.",Mr. Brad R. McCarthy CPA,Healthcare,AU,,61 2 9667 4411,Century Estate,Alexandria,NSW,2015,,0,https://financialmodelingprep.com/image-stock/PARNF.png,2014-06-18,True,False,False,False,False
